Perrigo Company plc (PRGO)

Market Cap	4.21B
Revenue (ttm)	4.65B
Net Income (ttm)	-4.10M
Shares Out	135.51M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	18.73
Dividend	$1.09 (3.69%)
Ex-Dividend Date	Nov 30, 2023

Volume	3,158,514
Open	30.92
Previous Close	30.91
Day's Range	29.34 - 31.07
52-Week Range	26.81 - 40.28
Beta	0.90
Analysts	Strong Buy
Price Target	44.25 (+49.39%)
Earnings Date	Nov 7, 2023

About PRGO

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, w...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Dec 16, 1991
• Employees: 8,900
• Stock Exchange: NYSE
• Ticker Symbol: PRGO

Financial Performance

In 2022, PRGO's revenue was $4.45 billion, an increase of 7.56% compared to the previous year's $4.14 billion. Losses were -$140.60 million, 104.1% more than in 2021.

Analyst Forecast

According to 4 analysts, the average rating for PRGO stock is "Strong Buy." The 12-month stock price forecast is $44.25, which is an increase of 49.39% from the latest price.

Price Target

$44.25

(49.39% upside)

Analyst Consensus: Strong Buy